Wir verwenden standardmäßig essenzielle Cookies (Anmeldung, deine gespeicherten Ziele/Stacks). Mit deiner Erlaubnis aktivieren wir außerdem datenschutzfreundliche Analytik (Vercel Web Analytics, anonyme Ladezeit-Metriken) und Fehler-Replay-Diagnostik (Sentry — DOM-Snapshots nur, wenn ein Fehler auftritt), damit wir Bugs schneller beheben können. Mehr über Cookies erfahren

Aspirin (niedrig dosiert) – Forschungsarchiv – Seite 18 von 60 | SupStack

Aspirin (niedrig dosiert) – Forschungsarchiv

Studien 1801–1850 von 3914, neueste zuerst

Die 1000 neuesten Studien – mit Evidenz-Zusammenfassung, Filtern und Suche – stehen auf der Hauptseite. Dieses Archiv listet die übrigen, 50 pro Seite. Zurück zur Hauptseite

1801RCT2010

Dippel DW, Maasland L, Halkes P, Kappelle LJ, Koudstaal PJ, Algra A · Stroke (2010)

Für dieses Zitat ist keine Zusammenfassung hinterlegt — öffne die Arbeit, um das Abstract zu lesen.

Aspirin (niedrig dosiert) – Forschungsarchiv

Prevention with low-dose aspirin plus dipyridamole in patients with disabling stroke.

Treatment of aspirin-resistant patients with omega-3 fatty acids versus aspirin dose escalation.

Aspirin for prevention of cardiovascular events in a general population screened for a low ankle brachial index: a randomized controlled trial.

[Recurrent thromboses and hemorrhagic complications in patients with antiphospholipid syndrome during therapy with warfarin plus aspirin].

Adjunctive treatment of chronic periodontitis with daily dietary supplementation with omega-3 Fatty acids and low-dose aspirin.

Antiplatelet therapy in combination with rt-PA thrombolysis in ischemic stroke (ARTIS): rationale and design of a randomized controlled trial.

Aspirin-associated iron loss as an anticancer mechanism.

Effect of intravenous tirofiban and aspirin in reducing short-term and long-term neurologic deficit in patients with ischemic stroke: a double-blind randomized trial.

The effect of aspirin on endothelial progenitor cell biology: preliminary investigation of novel properties.

Aspirin plus clopidogrel therapy increases early venous graft patency after coronary artery bypass surgery a single-center, randomized, controlled trial.

Dose-related effect of aspirin on laboratory-defined platelet aggregation and clinical outcome after coronary stenting.

[Acetylsalicylic acid in the primary and secondary prevention of vascular disease].

Aspirin plus heparin or aspirin alone in women with recurrent miscarriage.

Aspirin in Alzheimer's disease: increased risk of intracerebral hemorrhage: cause for concern?

Demonstration of the analgesic efficacy and dose-response of acetylsalicylic acid with pseudoephedrine.

Addition of cilostazol to aspirin and a thienopyridine for prevention of restenosis after coronary artery stenting: a meta-analysis.

Effects of acetaminophen, naproxen, and acetylsalicylic acid on tapentadol pharmacokinetics: results of two randomized, open-label, crossover, drug-drug interaction studies.

Baseline plasma total homocysteine and adenoma recurrence: results from a double blind randomized clinical trial of aspirin and folate supplementation.

Adjuvant aspirin therapy reduces symptoms of schizophrenia spectrum disorders: results from a randomized, double-blind, placebo-controlled trial.

Aspirin resistance in hypertensive patients.

Esophageal mucosal injury with low-dose aspirin and its prevention by rabeprazole.

Effect of aspirin, other NSAIDs, and statins on PSA and PSA velocity.

Low-dose aspirin therapy and hypertensive pregnancy complications in unselected IVF and ICSI patients: a randomized, placebo-controlled, double-blind study.

Dose comparisons of clopidogrel and aspirin in acute coronary syndromes.

Rationale and design of a randomized, double-blind trial comparing the effects of a 3-month clopidogrel-aspirin regimen versus aspirin alone for the treatment of high-risk patients with acute nondisabling cerebrovascular event.

Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial.

Combination of heparin and aspirin is superior to aspirin alone in enhancing live births in patients with recurrent pregnancy loss and positive anti-phospholipid antibodies: a meta-analysis of randomized controlled trials and meta-regression.

Low-dose aspirin therapy to prevent ovarian hyperstimulation syndrome.

The efficacy and safety of clopidogrel in vascular surgery patients with immediate postoperative asymptomatic troponin T release for the prevention of late cardiac events: Rationale and design of the Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echo-VII (DECREASE-VII) trial.

Aspirin use and the risk of gastric cancer: a meta-analysis.

Aspirin resistance is associated with glycemic control, the dose of aspirin, and obesity in type 2 diabetes mellitus.

Validation of a procedure to assess ASA-response in patients with decreased, initial TRAP induced aggregation.

Serial change in platelet activation markers with aspirin and clopidogrel after acute ischemic stroke.

Antiplatelet effects of aspirin with phytosterols: comparison with non-enteric coated aspirin alone.

Effects of aspirin and NO-aspirin (NCX 4016) on platelet function and coagulation in human endotoxemia.

Aspirin for primary prevention of cardiovascular events in patients with diabetes: A meta-analysis.

[Effect of tongxinluo capsule on platelet aggregation function in patients with aspirin resistance].

Role of aspirin in tuberculous meningitis: a randomized open label placebo controlled trial.

Systematic review: Helicobacter pylori and the risk of upper gastrointestinal bleeding risk in patients taking aspirin.

WITHDRAWN: Antihistamines versus aspirin for itching in late pregnancy.

Clopidogrel provides significantly greater inhibition of platelet activity than aspirin when combined with atorvastatin after coronary artery bypass grafting: a prospective randomized study.

Cilostazol for prevention of secondary stroke (CSPS 2): an aspirin-controlled, double-blind, randomised non-inferiority trial.

A randomized trial of aspirin at clinically relevant doses and nitric oxide formation in humans.

Warfarin and aspirin use in atrial fibrillation among practicing cardiologist (from the AFFECTS Registry).

Platelet hyperfunction is decreased by additional aspirin loading in patients presenting with myocardial infarction on daily aspirin therapy.

Aspirin for the prevention of cardiovascular morbidity.

Addition of cilostazol reduces biological aspirin resistance in aspirin users with ischaemic stroke: a double-blind randomized clinical trial.

The effect on mortality of antipyretics in the treatment of influenza infection: systematic review and meta-analysis.

Clopidogrel plus aspirin versus aspirin alone for reducing embolisation in patients with acute symptomatic cerebral or carotid artery stenosis (CLAIR study): a randomised, open-label, blinded-endpoint trial.

The contribution of cyclooxygenase-1 and -2 to persistent thromboxane biosynthesis in aspirin-treated essential thrombocythemia: implications for antiplatelet therapy.